Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19.
Adult
COVID-19
/ diagnosis
COVID-19 Nucleic Acid Testing
/ methods
Cohort Studies
Hospitalization
Humans
Male
Masks
Middle Aged
RNA, Viral
/ isolation & purification
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction
/ methods
SARS-CoV-2
/ isolation & purification
Time Factors
Tunisia
Virus Shedding
COVID-19
Coronavirus disease 2019
Negative conversion
SARS-CoV-2
Tunisia
Viral shedding
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
19
10
2020
revised:
16
02
2021
accepted:
23
02
2021
pubmed:
2
3
2021
medline:
21
5
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
The aim of this study was to identify the factors influencing the delay in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA negative conversion. A cohort study was conducted that included patients with coronavirus disease 2019 (COVID-19) admitted to the Tunisian national containment center. Follow-up consisted of a weekly RT-PCR test. Multivariate Cox regression analysis was performed to determine independent predictors associated with negative RNA conversion. Among the 264 patients included, the median duration of viral clearance was 20 days (interquartile range (IQR) 17-32 days). The shortest duration was 9 days and the longest was 58 days. Factors associated with negative conversion of viral RNA were symptoms such as fatigue, fever, and shortness of breath (hazard ratio (HR) 0.600, 95% confidence interval (CI) 0.401-0.897) and face mask use when exposed to COVID-19 cases (HR 2.006, 95% CI 1.247-3.228). The median time to RNA viral conversion was 18 days (IQR 16-21 days) when using masks versus 23 days (IQR 17-36 days) without wearing masks, and 24 days (IQR 18-36 days) for symptomatic patients versus 20 days (IQR 16-30 days) for asymptomatic patients. The results of this study revealed that during SARS-CoV-2 infection, having symptoms delayed viral clearance, while wearing masks accelerated this conversion. These factors should be taken into consideration for the strategy of isolating infected patients.
Identifiants
pubmed: 33647508
pii: S1201-9712(21)00175-2
doi: 10.1016/j.ijid.2021.02.089
pmc: PMC7910140
pii:
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
463-469Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Chest. 2020 Nov;158(5):1876-1884
pubmed: 32569635
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Apr 10;41(4):485-488
pubmed: 32141279
Int J Infect Dis. 2020 Jul;96:531-537
pubmed: 32425636
Sci Total Environ. 2020 Aug 1;728:138812
pubmed: 32335406
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452
pubmed: 32780793
BMJ Open. 2020 Sep 2;10(8):e040380
pubmed: 32878768
Chest. 2013 Jan;143(1):196-206
pubmed: 23276842
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
Influenza Other Respir Viruses. 2013 Sep;7(5):833-7
pubmed: 23279949
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Med Virol. 2021 Jan;93(1):506-512
pubmed: 32644223
J Infect Chemother. 2021 Jan;27(1):70-75
pubmed: 32950393
N Engl J Med. 2020 Oct 29;383(18):e101
pubmed: 32897661
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Hum Reprod Update. 2005 Jul-Aug;11(4):411-23
pubmed: 15817524
Exp Gerontol. 2007 May;42(5):400-6
pubmed: 17218073
J Gen Intern Med. 2020 Oct;35(10):3063-3066
pubmed: 32737790
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
J Infect Dis. 2020 Aug 17;222(6):910-918
pubmed: 32614392
Chin Med J (Engl). 2020 May 5;133(9):1039-1043
pubmed: 32118639
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
Front Med (Lausanne). 2020 Aug 28;7:562
pubmed: 32984389